MedPath

Digitized Grip Strength

Not Applicable
Conditions
Rheumatoid Arthritis
Interventions
Device: Digitized sensor
Registration Number
NCT02197507
Lead Sponsor
University Hospital, Montpellier
Brief Summary

Rheumatoid arthritis (RA) is the most common chronic inflammatory arthritis in adults. Monitoring of disease activity is based on Disease Activity Score 28 (DAS 28). There are also validated questionnaires for self-assessment of the disease by the patient. Grip strength measured using a digitized sensor used by the patient could be an additional tool to the remote monitoring of patients with RA.

Main Objective : To evaluate the correlation between the measurement of grip strength in the dominant hand measured by a digital sensor and activity of RA assessed by DAS 28

Secondary objective : Evaluate the correlation between grip strength of the dominant hand and :

* scores of fatigue and pain (VAS and FACIT)

* the self-assessment scores known in RA : functional index Health Assessment Questionnaire (HAQ) and scores of activity RAPID3 and RADAI5.

It is a cross-sectional study involving 150 patients followed in our department for RA. Grip strength of the dominant hand will be measured by a digitalized sensor during a single visit integrating into the routine monitoring of patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
150
Inclusion Criteria
  • Rheumatoid arthritis whatever its activity
  • Above 18 years old patients
Exclusion Criteria
  • Other condition that may affect the level of fatigue and / or grip strength
  • Insufficient level of understanding to perform the measurement and self-report questionnaires

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
RA patientsDigitized sensor-
Primary Outcome Measures
NameTimeMethod
grip strengthvisit 1

Evaluate the correlation between the measurement of grip strength in the dominant hand measured by a digital sensor and activity of RA assessed by DAS 28

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

UH Montpellier

🇫🇷

Montpellier, France

© Copyright 2025. All Rights Reserved by MedPath